Editorial: Advances in Cell and Gene Therapy in Treating Neural Diseases

• Raymond Ching-Bong Wong,
• Raymond Ching-Bong Wong,
• Raymond Ching-Bong Wong,
• Kouichi Hasegawa,
• Kouichi Hasegawa,
• Gary S. L. Peh,
• Gary S. L. Peh,
• Guei-Sheung Liu,
• Guei-Sheung Liu,
• Guei-Sheung Liu

Affiliations

Raymond Ching-Bong Wong

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia

Raymond Ching-Bong Wong

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia

Raymond Ching-Bong Wong

Shenzhen Eye Hospital, Shenzhen University School of Medicine, Shenzhen, China

Kouichi Hasegawa

Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan

Kouichi Hasegawa

StemRIM Institute for Regeneration-Inducing Medicine, Osaka University, Osaka, Japan

Gary S. L. Peh

Tissue Engineering and Cell Therapy, Singapore Eye Research Institute, Singapore, Singapore

Gary S. L. Peh

The Ophthalmology & Visual Sciences Academic Clinical Programme (EYE-ACP), Duke-NUS Graduate Medical School, Singapore, Singapore

Guei-Sheung Liu

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia

Guei-Sheung Liu

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia

Guei-Sheung Liu

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia